Superbug showdown: fecal transplants vs probiotics in war on antibiotic resistance

NCT ID NCT07094984

Recruiting now Disease control Sponsor: Medical University of Warsaw Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 31 times

Summary

This study tests three approaches to remove dangerous antibiotic-resistant bacteria from the gut: fecal microbiota transplantation (FMT) after antibiotics, probiotic therapy, or a special diet. Researchers aim to find a strategy to prevent these superbugs from causing infections. The trial involves 360 adults colonized with resistant bacteria like ESBL, CRE, VRE, or MRSA.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIMICROBIAL DRUG RESISTANCE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Klinika Hematologii, Transplantologii i Chorób Wewnętrznych
RECRUITING

Warsaw, Poland

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ANTIMICROBIAL DRUG RESISTANCE DRUG RESISTANCE, BACTERIAL